$PFE Recent News Inversions are not such a swe
Post# of 72711
Posted On: 08/25/2014 11:46:19 AM
$PFE Recent News
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Jackson Hole And Complacency 12:18 a.m. Aug. 24, 2014 - Seeking Alpha
Despite Gains, European Pharma Looks Sickly 1:41 a.m. Aug. 23, 2014 - Barrons.com
Durata exercises milestone payment deferral right 8:02 p.m. Aug. 22, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog 5:55 p.m. Aug. 22, 2014 - Zacks.com
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - CNW Group
FDA approves single-pill regimen HIV med 3:32 p.m. Aug. 22, 2014 - Seeking Alpha
Tonix Could Match Pfizer's Biggest Drug's Best Market 9:43 a.m. Aug. 22, 2014 - Seeking Alpha
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 22, 2014 - Zacks.com
Sweet Lawsuit Home, Alabama 7:35 p.m. Aug. 21, 2014 - The Wall Street Journal Interactive Edition
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog 5:30 p.m. Aug. 21, 2014 - Zacks.com
FDA approves Eliquis label expansion 3:51 p.m. Aug. 21, 2014 - Seeking Alpha
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? 3:50 p.m. Aug. 21, 2014 - Seeking Alpha
ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms 2:14 p.m. Aug. 21, 2014 - 247WallSt.com
Contract Researcher Parexel Sees Growth In Biotech 2:00 p.m. Aug. 21, 2014 - Investors Business Daily
Pfizer may make another run at AstraZeneca by year end 11:47 a.m. Aug. 21, 2014 - Seeking Alpha
Illumina Forms Partnerships With Big Pharma Firms 11:03 a.m. Aug. 21, 2014 - Investors Business Daily
Grappling with Inversion-Induced Tax Hits 9:35 a.m. Aug. 21, 2014 - The Wall Street Journal Interactive Edition
Why AstraZeneca (AZN) Stock Is Higher Today 9:35 a.m. Aug. 21, 2014 - TheStreet.com
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog 4:27 p.m. Aug. 20, 2014 - Zacks.com
GlaxoSmithKline: The Bad Isn't All That Bad 3:39 p.m. Aug. 20, 2014 - Seeking Alpha
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Today - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Premier Biotechnology & Anti-CTLA4 8:02 a.m. Aug. 18, 2014 - ACCESSWIRE
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA 8:00 a.m. Aug. 18, 2014 - BusinessWire - BZX
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 5:01 p.m. Aug. 14, 2014 - BusinessWire - BZX
Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older 5:43 p.m. Aug. 13, 2014 - BusinessWire - BZX
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic PeripheralNeuropathy Lyrica® Studies Conducted in China 5:03 p.m. Aug. 12, 2014 - BusinessWire - BZX
Study Links Viagra(R) to Skin Cancer 11:20 a.m. Aug. 12, 2014 - Marketwire
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Renal Pain Global Clinical Trials Review, H2, 2014 4:37 p.m. Aug. 11, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults 8:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Jackson Hole And Complacency 12:18 a.m. Aug. 24, 2014 - Seeking Alpha
Despite Gains, European Pharma Looks Sickly 1:41 a.m. Aug. 23, 2014 - Barrons.com
Durata exercises milestone payment deferral right 8:02 p.m. Aug. 22, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog 5:55 p.m. Aug. 22, 2014 - Zacks.com
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - CNW Group
FDA approves single-pill regimen HIV med 3:32 p.m. Aug. 22, 2014 - Seeking Alpha
Tonix Could Match Pfizer's Biggest Drug's Best Market 9:43 a.m. Aug. 22, 2014 - Seeking Alpha
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 22, 2014 - Zacks.com
Sweet Lawsuit Home, Alabama 7:35 p.m. Aug. 21, 2014 - The Wall Street Journal Interactive Edition
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog 5:30 p.m. Aug. 21, 2014 - Zacks.com
FDA approves Eliquis label expansion 3:51 p.m. Aug. 21, 2014 - Seeking Alpha
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? 3:50 p.m. Aug. 21, 2014 - Seeking Alpha
ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms 2:14 p.m. Aug. 21, 2014 - 247WallSt.com
Contract Researcher Parexel Sees Growth In Biotech 2:00 p.m. Aug. 21, 2014 - Investors Business Daily
Pfizer may make another run at AstraZeneca by year end 11:47 a.m. Aug. 21, 2014 - Seeking Alpha
Illumina Forms Partnerships With Big Pharma Firms 11:03 a.m. Aug. 21, 2014 - Investors Business Daily
Grappling with Inversion-Induced Tax Hits 9:35 a.m. Aug. 21, 2014 - The Wall Street Journal Interactive Edition
Why AstraZeneca (AZN) Stock Is Higher Today 9:35 a.m. Aug. 21, 2014 - TheStreet.com
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog 4:27 p.m. Aug. 20, 2014 - Zacks.com
GlaxoSmithKline: The Bad Isn't All That Bad 3:39 p.m. Aug. 20, 2014 - Seeking Alpha
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Today - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Premier Biotechnology & Anti-CTLA4 8:02 a.m. Aug. 18, 2014 - ACCESSWIRE
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA 8:00 a.m. Aug. 18, 2014 - BusinessWire - BZX
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 5:01 p.m. Aug. 14, 2014 - BusinessWire - BZX
Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older 5:43 p.m. Aug. 13, 2014 - BusinessWire - BZX
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic PeripheralNeuropathy Lyrica® Studies Conducted in China 5:03 p.m. Aug. 12, 2014 - BusinessWire - BZX
Study Links Viagra(R) to Skin Cancer 11:20 a.m. Aug. 12, 2014 - Marketwire
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Renal Pain Global Clinical Trials Review, H2, 2014 4:37 p.m. Aug. 11, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults 8:00 a.m. Aug. 7, 2014 - BusinessWire - BZX
Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼